Relapsed Small Lymphocytic Lymphoma
4 clinical trials · Condition
◉ Watch Relapsed Small Lymphocytic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL (NCT03639324) | Virginia Commonwealth University | 2020-10-02 |
| Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187) | H. Lee Moffitt Cancer Center and Research Institute | 2019-12-06 |
| UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668) | Masonic Cancer Center, University of Minnesota | 2017-05-15 |
Track Relapsed Small Lymphocytic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.